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8 INTERMITTENT CLAUDICATION
81
INTRODUCTION AND CHARACTERISATION OF
PATIENTS
81.1
Definition and Nomenclature for Intermittent
Claudication
The word claudication is derived from "claudicatio,"
meaning "to limp." It is said to have originated when
physiologists, studying arterial pressure by cannulat-
ing the femoral arteries of horses and then ligating
their femoral arteries, observed them to limp before
stopping inierinittentlu, as they ran in the fields after-
wards. The term intermittent claudication has thus
come to mean leg pain sufficient to cause the patient to
stop, which is produced by exercise and relieved by
rest, and is caused by arterial occlusive disease. It
could be added that the pain is reproducibhj caused by
a given degree of exercise and relieved within minutes
by rest. These and other characteristics are discussed
further under B 2.1, Clinical Evaluation (p 548) One
who claudicates is called a claudicani, although the
term claudicator is also frequently used. Other diseases
that cause discomfort with ambulation have been
referred to as claudication, as in neurospinal claudica-
tion, which is discussed later, but these conditions
should either be grouped under pseudoclaudication
or be preceded by a defining word such as neurospinal.
When intermittent precedes the word claudication, the
cause is presumed to be arterial occlusive in origin,
although the simpler term claudication is mostly used
throughout this text.
81.1.1
Patient Characteristics
Intermittent claudication (IC) can be caused by any
occlusive lesion in the arterial supply of the leg mus-
cles that interferes sufficiently enough with blood flow
to produce ischemic pain with exercise. In the Western
world at least, it is overwhelmingly the result of ath-
erosclerosis and the focus of this document, PAD.
Other causes are discussed later under differential
diagnosis (see B 2.1.2, P 549). Those with IC from PAD
will be predominantly older patients, predominantly
male, and almost invariably with identifiable risk fac-
tors for atherosclerosis, as previously detailed in A 2.2,
Epidemiology-Intermittent Claudication (p 54).
Also detailed earlier (Epidemiology, A 2.4 and A 2.5,
pp 514 and p 516) are the facts that, in contrast to
patients with chronic critical limb ischaemia, those
with IC tend to have single rather than multi-level dis-
ease, to be somewhat younger, to have less atheroscle-
rotic disease elsewhere, and a better longevity outlook
(in terms of remaining years, not age at death). They
also have a much more benign outlook for future limb
loss. These characteristics should be kept in mind in
reading the subsequent sections. It also should be
remembered that IC depends on activity level. Those
with arthritis and other conditions preventing arnbu-
lation and otherwise sedentary patients with arterial
occlusive disease equivalent to that producing IC in
active patients may be completely asymptomatic in
this regard.
81.1,2
Haemodynamic Abnormalities
The pathophysiology of PAD, whether it produces
claudication, rest pain, or tissue loss, is primarily
accounted for by the haernodynarnic severity and
number of occlusive lesions in the peripheral circula-
tion . Haemodynamic significance of an arterial steno-
sis is a function not only of the percentage stenosis,
but also of flow velocity across the lesion.J.2 For exam-
ple, at rest, blood flow velocity in the femoral artery
may be as low as 20 cm/s. At this velocity, a stenosis
will not become haemodynamically significant until it
is 90% occlusive. Above 90% stenosis, flow and pres-
sure rapidly decrease with increasing obstruction.
However, with exercise in the normal extremity, flow
velocity may increase to as high as 150 cm/s. At these
higher flow velocities, a stenosis becomes haerno-
dynamically significant at approximately 50%. Thus,
patients with claudication have normal flow to skele-
tal muscle at rest, but markedly impaired flow to meet
metabolic demand with exercise.
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On average, patients with single-segment disease,
such as occlusion of the iliac vessels, and good collat-
eral development will have mild claudication. With
more extensive disease, claudication symptoms
become more severe. Symptoms cannot be entirely
explained by the severity of reduction in blood pres-
sure. For example, the ABPI in patients with claudica-
tion is not well correlated with their exercise perform-
ance on a treadmill, or with the severity of symptoms
in the community setting.v'>
B 1.1.3
Metabolic and Neurological Abnormalities
Peripheral arterial disease is not simply a haemody-
namic disorder. Additional factors are involved in
the pathogenesis of this disease. Key factors include
de conditioning, because these patients are very
inactive. In addition, several studies have shown
skeletal muscle injury in patients with chronic arte-
rial occlusive disease. This injury has been charac-
terised as a distal axonal denervation leading to loss
of muscle fibres and mild atrophy of the affected
muscle.s-' Muscle strength is reduced in these
patients, which leads to a compromise of muscle
function and exercise performance. In addition,
oxidative metabolism is severely impaired in PAD
patients, and these changes cannot be accounted for
simply by the reduction in blood flow.
Several studies have observed that patients with
peripheral arterial disease accumulate intermedi-
ates of oxidation such as acylcarnitines." These com-
pounds are formed from acyl-CoA intermediates in
the oxidation of fatty acids, proteins, and carbohy-
drates. This accumulation has functional signifi-
cance in that patients with the greatest degree of
metabolic disruption and accumulation of acylcar-
nitines have the most severely impaired exercise
performance. Further evidence for altered metabo-
lism comes from magnetic resonance spectroscopy.
Several studies have indicated that patients with
PAD have not only impaired resynthesis of phos-
phocreatinine, but abnormally high levels of adeno-
sine diphosphate (ADP).9.1o These findings are con-
sistent with a metabolic myopathy, which occurs in
chronic forms of the disease.
In summary, the pathogenesis of PAD is initiated
by atherosclerotic occlusions of the major conduit
vessels in the lower extremity. However, over time
the disease affects the skeletal muscle neurological
and metabolic function, leading to further impair-
ments in muscle performance and patient function-
al status.
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8 2 EVALUATION
82.1
Clinical Evaluation of Intermittent Claudication
B 2.1.1
History
Chronic arterial insufficiency of the lower extremity
causes two very characteristic types of pain: intermit-
tent claudication and ischaemic rest pain.
"Claudication," although derived from the Latin word
for "limp," has by usage come to mean a pain or dis-
comfort associated with exercise. The level and extent
of the arterial occlusive disease determines the loca-
tion of the pain and the amount of exercise needed to
produce it. Lesions in the femoral, popliteal, or tibial
arteries produce a cramping pain in the calf muscles.
